SDZ EBS Week ended 31 Jul 2026

Weekly Investor Report

Name: SDZ weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Sandoz Group AG · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data

Latest close 66.06 CHF

3.8% latest week

Weekly setup

Mixed setup

The weekly trend is active. Price is 2.2% above the Trend Line and sits at 72.4% of its 52-week range. The latest completed week returned 3.8%, after a -8.7% four-week move. The latest news-sentiment score is 53/100.

Setup score 59 out of 100

Latest Close 66.06 CHF 31 Jul 2026

1W Return 3.8% latest completed week

4W Return -8.7% short-term follow-through

12W Return -1.2% quarterly tape

Trend Breadth 100.0% 52 of 52 weeks active

Volume Ratio 1.4x vs 13-week average

What is working

The trend backdrop is active with a 59-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Next-week expectancy is positive at 62.17% based on similar historical setup states.

What could go wrong

Activity pressure is negative, which weakens the current setup.
14 reversal markers appear in the recent smart-money tape.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 3.8% Latest completed week; four-week move -8.7%. Indicator stack 100/36 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 62.17% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 24 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 2.2% above the Trend Line and sits at 72.4% of its 52-week range. The latest completed week returned 3.8%, after a -8.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

43.33 CHF 72.4% 74.72 CHF

Range location72.4%Shows where the latest close sits between the 52-week low and high.

Trend distance2.2%Price premium or discount versus the weekly Trend Line.

Fair-value gap55.3%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-11.6%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8212-week average 0.83

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.82Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers1414 reversal markers

No recent accumulation markers. 14 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -8.7% over four weeks, -1.2% over 12 weeks, and 43.1% over one year. The current trend has remained active for 59 consecutive weeks.

Performance by holding period

1W3.8%

4W-8.7%

12W-1.2%

26W9.3%

52W43.1%

Active trend streak59 weeks

Active weeks in one year52

Trend breadth100.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure-0.18Latest activity-pressure read.

Pressure change-138.0%Four-week change in activity pressure.

Leadership2.42Latest relative-leadership reading.

RS change-81.5%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 24 relevant articles.

4 positive · 19 neutral · 1 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-11.6%Distance below the 52-week high.

13-week volatility3.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher14 of 2612 weeks finished lower.

Best week+6.9%Week of 8 May.

Worst week-6.7%Week of 6 Mar.

Latest week+3.8%Week of 31 Jul.

Shape of recent returns

Strong gains6

Modest gains8

Flat weeks0

Modest losses9

Sharp losses3

Recent vol3.8%13-week weekly-return volatility.

Base vol3.3%52-week weekly-return volatility.

Up/down split28/24Count of positive and negative weeks in the 52-week window.

Average skew3.3% / -2.2%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorCH Healthcare

4-week rank36 / 40

Group average-1.1%

Trend breadth47.5%

Trend47.5%active weekly trend signals

MD62.5%positive activity pressure

RS42.5%positive relative leadership

Four-week leaders

KURN · EBS19.6%SOON · EBS8.1%YPSN · EBS7.8%METN · EBS7.4%SFZN · EBS6.6%

IndustryCH Drug Manufacturers - Specialty & Generic

4-week rank3 / 5

Group average-5.2%

Trend breadth80.0%

Trend80.0%active weekly trend signals

MD40.0%positive activity pressure

RS80.0%positive relative leadership

Four-week leaders

SFZN · EBS6.6%GALD · EBS-2.1%SDZ · EBS-8.7%CURN · EBS-10.6%PPGN · EBS-11.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

Indicator analysis65/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 11/12.

Activity pressure 0.82; 14 reversal markers Next-Week ExpectancyPositive 62.17%

Next-week expectancy is positive with a 62.17% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 24 relevant articles.

How Investors Are Reacting To Sandoz Group (SWX:SDZ) Leadership Overhaul In Generics Manufacturing And M&A Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	66.06 CHF	3.8%	64.62 CHF	42.54 CHF	-0.18	2.42	3.6M	On
24 Jul 2026	63.62 CHF	-3.2%	64.32 CHF	42.38 CHF	0.25	-0.93	4.0M	On
17 Jul 2026	65.74 CHF	-3.0%	64.13 CHF	42.23 CHF	0.60	2.49	4.2M	On
10 Jul 2026	67.78 CHF	-6.3%	63.85 CHF	42.07 CHF	0.63	6.85	3.3M	On
3 Jul 2026	72.34 CHF	0.6%	63.48 CHF	41.89 CHF	0.48	13.06	3.2M	On
26 Jun 2026	71.88 CHF	5.8%	62.97 CHF	41.68 CHF	-0.10	15.05	636.2K	On
19 Jun 2026	67.92 CHF	1.3%	62.44 CHF	41.47 CHF	-0.47	12.59	2.0M	On
12 Jun 2026	67.04 CHF	4.1%	61.98 CHF	41.28 CHF	-0.67	12.31	579.8K	On
5 Jun 2026	64.40 CHF	-1.8%	61.55 CHF	41.10 CHF	-0.74	11.15	354.5K	On
29 May 2026	65.60 CHF	1.8%	61.15 CHF	40.93 CHF	-0.60	12.58	2.6M	On
22 May 2026	64.44 CHF	-1.6%	60.72 CHF	40.75 CHF	-0.63	11.65	3.0M	On
15 May 2026	65.48 CHF	-2.1%	60.21 CHF	40.58 CHF	-0.63	16.66	3.1M	On
8 May 2026	66.88 CHF	6.9%	59.62 CHF	40.39 CHF	-0.52	21.25	3.2M	On
1 May 2026	62.54 CHF	-1.2%	59.01 CHF	40.20 CHF	-0.47	14.11	3.3M	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.